- Home
- LRFC vs VTVT Comparison
LRFC vs VTVT Comparison
Compare LRFC & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRFC
- VTVT
- Stock Information
- Founded
- LRFC 2013
- VTVT 2015
- Country
- LRFC United States
- VTVT United States
- Employees
- LRFC N/A
- VTVT N/A
- Industry
- LRFC Finance: Consumer Services
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- LRFC Finance
- VTVT Health Care
- Exchange
- LRFC Nasdaq
- VTVT Nasdaq
- Market Cap
- LRFC 47.6M
- VTVT 56.7M
- IPO Year
- LRFC 2013
- VTVT 2015
- Fundamental
- Price
- LRFC $18.19
- VTVT $21.39
- Analyst Decision
- LRFC
- VTVT Strong Buy
- Analyst Count
- LRFC 0
- VTVT 2
- Target Price
- LRFC N/A
- VTVT $35.50
- AVG Volume (30 Days)
- LRFC 13.2K
- VTVT 9.3K
- Earning Date
- LRFC 05-08-2025
- VTVT 05-27-2025
- Dividend Yield
- LRFC 8.04%
- VTVT N/A
- EPS Growth
- LRFC N/A
- VTVT N/A
- EPS
- LRFC N/A
- VTVT N/A
- Revenue
- LRFC $20,544,000.00
- VTVT $1,017,000.00
- Revenue This Year
- LRFC N/A
- VTVT N/A
- Revenue Next Year
- LRFC N/A
- VTVT N/A
- P/E Ratio
- LRFC N/A
- VTVT N/A
- Revenue Growth
- LRFC 3.11
- VTVT N/A
- 52 Week Low
- LRFC $17.30
- VTVT $12.12
- 52 Week High
- LRFC $26.00
- VTVT $29.01
- Technical
- Relative Strength Index (RSI)
- LRFC 32.35
- VTVT 57.22
- Support Level
- LRFC $17.46
- VTVT $20.12
- Resistance Level
- LRFC $18.20
- VTVT $21.52
- Average True Range (ATR)
- LRFC 0.30
- VTVT 1.23
- MACD
- LRFC 0.16
- VTVT -0.09
- Stochastic Oscillator
- LRFC 46.79
- VTVT 67.00
About LRFC Logan Ridge Finance Corporation
Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.